German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Nicotinic acid derivatives (antituberculosis drugs). |
| Generic Name : | Pyrazinamide |
| Drug description : | White scored tablet marked MSD 504. |
| Presentation : | Tablets, pyrazinamide 500 mg . |
| Indications : | Treatment of tuberculosis only in conjunction with other anti- tuberculous drugs. |
| Adult Dosage : | 20-35 mg/kg daily in divided 20-35 mg/kg daily in divided doses; maximum 3 g daily. |
| Child Dosage : | Not recommended. |
| Contra Indications : | Liver disease. Lactation. Hyperuricaemia and/or acute gouty arthritis. |
| Special Precautions : | Perform frequent liver function tests and blood uric acid determinations. Renal insufficiency. History of gout or diabetes. Withdraw treatment if liver damage or hyperuricaemia accompanied by acute gouty arthritis occurs. Pregnancy. |
| Adverse Reactions : | Hepatic reactions, hepatomegaly, jaundice, gout, sideroblastic anaemia, arthralgia, anorexia, nausea, dysuria, malaise, urticaria, aggravation of peptic ulcer. |
| Manufacturer : | MSD |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org

Medical News Feed



